Off‐Label Therapies for COVID‐19—Are We All In This Together?

Author:

Alpern Jonathan D.123,Gertner Elie134

Affiliation:

1. HealthPartners Institute Bloomington Minnesota USA

2. Section of Infectious Diseases HealthPartners St. Paul Minnesota USA

3. Department of Medicine University of Minnesota Minneapolis Minnesota USA

4. Section of Rheumatology HealthPartners St. Paul Minnesota USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference10 articles.

1. Race to find COVID-19 treatments accelerates

2. McCreary E.&Pogue J.M.COVID‐19 treatment: a review of early and emerging options. Open forum infectious diseases . Accessed March 24 2020.

3. Bloomberg.Hospitals stockpile drug trump says could treat Covid‐19.

4. Lack of Benefit of High-Dose Vitamin C, Thiamine, and Hydrocortisone Combination for Patients With Sepsis

5. US Food and Drug Administration.Request for emergency use authorization for use of chloroquine phosphate or hydroxychloroquine sulfate supplied from the strategic national stockpile for treatment of 2019 coronavirus disease. .

Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3